provides essential context
Chavda V, Chaurasia B, Garg K, Deora H, Umana GE, Palmisciano P, Scalia G, Lu B
Regular follow-up with a registered dietitian experienced in obesity medicine can provide personalized guidance and troubleshooting for patients struggling to maintain adequate protein intake while on GLP-1 therapy
Optogenetic activation of PVN GLP-1R DVC projections suppresses food intake energy state dependently, and blocking its synaptic release or ablating GLP-1Rs in the presynaptic neurons impairs metabolic health
Gastrointestinal side effects have generally been consistent with those of incretin based therapies
Hence, there is an unmet need to provide current and future head and neck cancer patients with preventative therapies to protect salivary gland function